meglumine antimoniate has been researched along with Inflammation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva, JHM; de Barros, NB; de Figueiredo Nicolete, LD; Dos Santos Ferreira, A; Macedo, SRA; Nicolete, R; Valentim-Silva, JR | 1 |
| Bordignon, J; Conchon Costa, I; Costa, IN; da Silva, SS; Fanti, JR; Felipe, I; Mizokami, SS; Pavanelli, WR; Verri, WA | 1 |
| Alves, MP; Daher, EF; Henn, GA; Martins, AM; Meneses, GC; Montenegro, BL; Oliveira, MJ; Rocha, HA; Sampaio, AM; Silva, GB | 1 |
| Araújo, EJ; Conchon-Costa, I; da Silva, SS; Fanti, JR; Felipe, I; Kawakami, NY; Miranda, MM; Mizokami, SS; Panis, C; Pavanelli, WR; Sforcin, JM; Teixeira, FH; Verri, WA; Watanabe, MA | 1 |
| Bulut, V; Gur, S; Gurel, MS; Kocyigit, A; Ulukanligil, M | 1 |
| Benjelloune, A; Berraho, A; Charif Chefchaouni, M; El Lyacoubi, M; Lamrani, R | 1 |
1 trial(s) available for meglumine antimoniate and Inflammation
| Article | Year |
|---|---|
Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Cytokines; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2002 |
5 other study(ies) available for meglumine antimoniate and Inflammation
| Article | Year |
|---|---|
Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophages.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Inflammation; Leishmania; Leishmaniasis; Macrophages; Meglumine Antimoniate; Mice; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Pentamidine; Signal Transduction; Toll-Like Receptors; Transcription Factor RelA | 2020 |
Glucantime reduces mechanical hyperalgesia in cutaneous leishmaniasis and complete Freund's adjuvant models of chronic inflammatory pain.
Topics: Acetylglucosaminidase; Animals; Chronic Pain; Cytokines; Freund's Adjuvant; Inflammation; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Peroxidase; Skin | 2018 |
Preliminary study on tubuloglomerular dysfunction and evidence of renal inflammation in patients with visceral leishmaniasis.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Biomarkers; Case-Control Studies; Chemokine CCL2; Female; Humans; Inflammation; Kidney; Kidney Diseases; Leishmaniasis, Visceral; Male; Malondialdehyde; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult | 2014 |
Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice.
Topics: Animals; Cytokines; Inflammation; Leishmania mexicana; Leishmaniasis, Cutaneous; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Propolis | 2016 |
[Cutaneous leishmaniasis of the lid].
Topics: Adult; Biopsy, Needle; Diagnosis, Differential; Eyelid Diseases; Female; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2002 |